Last reviewed · How we verify
Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6
A single-arm, multi-center, clinical study to assess the safety profile of the Tandem t:slim X2 with Control-IQ system in children with T1D aged 2-6 years old under free living condition
Details
| Lead sponsor | University of Virginia |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 12 |
| Start date | Thu Sep 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Oct 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Type 1 Diabetes
Interventions
- Tandem t:slim X2 with Control-IQ Technology + Dexcom G6
Countries
United States